MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis – JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib – Preliminary Data From the MANIFEST StudyJohn Mascarenhas, Vikas Gupta, Andrea Patriarca et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 13